nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Timolol—coronary artery disease	0.211	0.54	CrCtD
Levobunolol—Penbutolol—coronary artery disease	0.179	0.46	CrCtD
Levobunolol—ADRB1—coronary artery disease	0.0899	0.543	CbGaD
Levobunolol—ADRB2—coronary artery disease	0.0756	0.457	CbGaD
Levobunolol—Bupranolol—Gemfibrozil—coronary artery disease	0.058	0.242	CrCrCtD
Levobunolol—Timolol—Penbutolol—coronary artery disease	0.0553	0.231	CrCrCtD
Levobunolol—ADRB2—Penbutolol—coronary artery disease	0.0407	0.296	CbGbCtD
Levobunolol—ADRB1—Penbutolol—coronary artery disease	0.0401	0.291	CbGbCtD
Levobunolol—ADRB2—Timolol—coronary artery disease	0.0287	0.208	CbGbCtD
Levobunolol—ADRB1—Timolol—coronary artery disease	0.0282	0.205	CbGbCtD
Levobunolol—Penbutolol—Timolol—coronary artery disease	0.027	0.113	CrCrCtD
Levobunolol—Carteolol—Penbutolol—coronary artery disease	0.0253	0.105	CrCrCtD
Levobunolol—Nadolol—Penbutolol—coronary artery disease	0.0253	0.105	CrCrCtD
Levobunolol—Bupranolol—Timolol—coronary artery disease	0.0215	0.0896	CrCrCtD
Levobunolol—Bupranolol—Penbutolol—coronary artery disease	0.0183	0.0762	CrCrCtD
Levobunolol—Propranolol—Penbutolol—coronary artery disease	0.00901	0.0376	CrCrCtD
Levobunolol—Timolol—ADRB1—coronary artery disease	0.000138	0.0887	CrCbGaD
Levobunolol—Carteolol—ADRB1—coronary artery disease	0.000123	0.0791	CrCbGaD
Levobunolol—Timolol—ADRB2—coronary artery disease	0.000116	0.0746	CrCbGaD
Levobunolol—Nadolol—ADRB1—coronary artery disease	0.00011	0.0705	CrCbGaD
Levobunolol—Bupranolol—ADRB1—coronary artery disease	0.000105	0.0672	CrCbGaD
Levobunolol—Carteolol—ADRB2—coronary artery disease	0.000104	0.0665	CrCbGaD
Levobunolol—Timolol—CYP2C19—coronary artery disease	0.0001	0.0642	CrCbGaD
Levobunolol—Salbutamol—ADRB1—coronary artery disease	9.84e-05	0.0632	CrCbGaD
Levobunolol—Penbutolol—ADRB1—coronary artery disease	9.57e-05	0.0615	CrCbGaD
Levobunolol—Nadolol—ADRB2—coronary artery disease	9.23e-05	0.0593	CrCbGaD
Levobunolol—Bupranolol—ADRB2—coronary artery disease	8.8e-05	0.0565	CrCbGaD
Levobunolol—Salbutamol—ADRB2—coronary artery disease	8.27e-05	0.0532	CrCbGaD
Levobunolol—Penbutolol—ADRB2—coronary artery disease	8.05e-05	0.0517	CrCbGaD
Levobunolol—Pindolol—ADRB1—coronary artery disease	6.9e-05	0.0443	CrCbGaD
Levobunolol—Pindolol—ADRB2—coronary artery disease	5.8e-05	0.0373	CrCbGaD
Levobunolol—Dyspnoea—Valsartan—coronary artery disease	5.67e-05	0.00114	CcSEcCtD
Levobunolol—Syncope—Losartan—coronary artery disease	5.65e-05	0.00114	CcSEcCtD
Levobunolol—Diarrhoea—Acetylsalicylic acid—coronary artery disease	5.65e-05	0.00114	CcSEcCtD
Levobunolol—Dizziness—Rosuvastatin—coronary artery disease	5.62e-05	0.00113	CcSEcCtD
Levobunolol—Urticaria—Ezetimibe—coronary artery disease	5.61e-05	0.00113	CcSEcCtD
Levobunolol—Nausea—Ticagrelor—coronary artery disease	5.61e-05	0.00113	CcSEcCtD
Levobunolol—Palpitations—Losartan—coronary artery disease	5.57e-05	0.00112	CcSEcCtD
Levobunolol—Shock—Captopril—coronary artery disease	5.56e-05	0.00112	CcSEcCtD
Levobunolol—Paraesthesia—Niacin—coronary artery disease	5.55e-05	0.00112	CcSEcCtD
Levobunolol—Feeling abnormal—Simvastatin—coronary artery disease	5.55e-05	0.00112	CcSEcCtD
Levobunolol—Arrhythmia—Ramipril—coronary artery disease	5.55e-05	0.00112	CcSEcCtD
Levobunolol—Loss of consciousness—Losartan—coronary artery disease	5.54e-05	0.00112	CcSEcCtD
Levobunolol—Confusional state—Perindopril—coronary artery disease	5.53e-05	0.00111	CcSEcCtD
Levobunolol—Hypotension—Trandolapril—coronary artery disease	5.52e-05	0.00111	CcSEcCtD
Levobunolol—Dyspnoea—Niacin—coronary artery disease	5.51e-05	0.00111	CcSEcCtD
Levobunolol—Hypotension—Enalapril—coronary artery disease	5.5e-05	0.00111	CcSEcCtD
Levobunolol—Alopecia—Ramipril—coronary artery disease	5.49e-05	0.0011	CcSEcCtD
Levobunolol—Paraesthesia—Pravastatin—coronary artery disease	5.47e-05	0.0011	CcSEcCtD
Levobunolol—Dizziness—Acetylsalicylic acid—coronary artery disease	5.46e-05	0.0011	CcSEcCtD
Levobunolol—Hypersensitivity—Fenofibrate—coronary artery disease	5.43e-05	0.00109	CcSEcCtD
Levobunolol—Dyspnoea—Pravastatin—coronary artery disease	5.43e-05	0.00109	CcSEcCtD
Levobunolol—Hypotension—Telmisartan—coronary artery disease	5.43e-05	0.00109	CcSEcCtD
Levobunolol—Arrhythmia—Timolol—coronary artery disease	5.42e-05	0.00109	CcSEcCtD
Levobunolol—Pain—Olmesartan—coronary artery disease	5.41e-05	0.00109	CcSEcCtD
Levobunolol—Shock—Perindopril—coronary artery disease	5.39e-05	0.00109	CcSEcCtD
Levobunolol—Confusional state—Furosemide—coronary artery disease	5.37e-05	0.00108	CcSEcCtD
Levobunolol—Chest pain—Losartan—coronary artery disease	5.37e-05	0.00108	CcSEcCtD
Levobunolol—Alopecia—Timolol—coronary artery disease	5.36e-05	0.00108	CcSEcCtD
Levobunolol—Urticaria—Simvastatin—coronary artery disease	5.35e-05	0.00108	CcSEcCtD
Levobunolol—Hypersensitivity—Clopidogrel—coronary artery disease	5.34e-05	0.00108	CcSEcCtD
Levobunolol—Erythema multiforme—Lisinopril—coronary artery disease	5.32e-05	0.00107	CcSEcCtD
Levobunolol—Headache—Rosuvastatin—coronary artery disease	5.32e-05	0.00107	CcSEcCtD
Levobunolol—Paraesthesia—Trandolapril—coronary artery disease	5.31e-05	0.00107	CcSEcCtD
Levobunolol—Hypersensitivity—Lovastatin—coronary artery disease	5.3e-05	0.00107	CcSEcCtD
Levobunolol—Asthenia—Fenofibrate—coronary artery disease	5.29e-05	0.00107	CcSEcCtD
Levobunolol—Pain—Niacin—coronary artery disease	5.29e-05	0.00106	CcSEcCtD
Levobunolol—Paraesthesia—Enalapril—coronary artery disease	5.29e-05	0.00106	CcSEcCtD
Levobunolol—Hypotension—Captopril—coronary artery disease	5.28e-05	0.00106	CcSEcCtD
Levobunolol—Dyspnoea—Trandolapril—coronary artery disease	5.27e-05	0.00106	CcSEcCtD
Levobunolol—Dyspnoea—Enalapril—coronary artery disease	5.25e-05	0.00106	CcSEcCtD
Levobunolol—Shock—Furosemide—coronary artery disease	5.24e-05	0.00106	CcSEcCtD
Levobunolol—Pruritus—Fenofibrate—coronary artery disease	5.22e-05	0.00105	CcSEcCtD
Levobunolol—Feeling abnormal—Olmesartan—coronary artery disease	5.22e-05	0.00105	CcSEcCtD
Levobunolol—Paraesthesia—Telmisartan—coronary artery disease	5.22e-05	0.00105	CcSEcCtD
Levobunolol—Pain—Pravastatin—coronary artery disease	5.21e-05	0.00105	CcSEcCtD
Levobunolol—Hypersensitivity—Ezetimibe—coronary artery disease	5.2e-05	0.00105	CcSEcCtD
Levobunolol—Asthenia—Clopidogrel—coronary artery disease	5.2e-05	0.00105	CcSEcCtD
Levobunolol—Confusional state—Losartan—coronary artery disease	5.19e-05	0.00104	CcSEcCtD
Levobunolol—Dyspnoea—Telmisartan—coronary artery disease	5.18e-05	0.00104	CcSEcCtD
Levobunolol—Asthenia—Lovastatin—coronary artery disease	5.17e-05	0.00104	CcSEcCtD
Levobunolol—Pruritus—Clopidogrel—coronary artery disease	5.13e-05	0.00103	CcSEcCtD
Levobunolol—Hypotension—Perindopril—coronary artery disease	5.12e-05	0.00103	CcSEcCtD
Levobunolol—Pruritus—Lovastatin—coronary artery disease	5.09e-05	0.00103	CcSEcCtD
Levobunolol—Paraesthesia—Captopril—coronary artery disease	5.07e-05	0.00102	CcSEcCtD
Levobunolol—Asthenia—Ezetimibe—coronary artery disease	5.07e-05	0.00102	CcSEcCtD
Levobunolol—Shock—Losartan—coronary artery disease	5.06e-05	0.00102	CcSEcCtD
Levobunolol—Urticaria—Valsartan—coronary artery disease	5.05e-05	0.00102	CcSEcCtD
Levobunolol—Nausea—Rosuvastatin—coronary artery disease	5.05e-05	0.00102	CcSEcCtD
Levobunolol—Diarrhoea—Fenofibrate—coronary artery disease	5.04e-05	0.00102	CcSEcCtD
Levobunolol—Dyspnoea—Captopril—coronary artery disease	5.04e-05	0.00101	CcSEcCtD
Levobunolol—Arrhythmia—Lisinopril—coronary artery disease	5.03e-05	0.00101	CcSEcCtD
Levobunolol—Urticaria—Olmesartan—coronary artery disease	5.03e-05	0.00101	CcSEcCtD
Levobunolol—Feeling abnormal—Pravastatin—coronary artery disease	5.02e-05	0.00101	CcSEcCtD
Levobunolol—Pruritus—Ezetimibe—coronary artery disease	5e-05	0.00101	CcSEcCtD
Levobunolol—Hypotension—Furosemide—coronary artery disease	4.98e-05	0.001	CcSEcCtD
Levobunolol—Alopecia—Lisinopril—coronary artery disease	4.97e-05	0.001	CcSEcCtD
Levobunolol—Pain—Telmisartan—coronary artery disease	4.97e-05	0.001	CcSEcCtD
Levobunolol—Hypersensitivity—Simvastatin—coronary artery disease	4.96e-05	0.000999	CcSEcCtD
Levobunolol—Diarrhoea—Clopidogrel—coronary artery disease	4.96e-05	0.000999	CcSEcCtD
Levobunolol—Asthenia—Eplerenone—coronary artery disease	4.96e-05	0.000999	CcSEcCtD
Levobunolol—Diarrhoea—Lovastatin—coronary artery disease	4.93e-05	0.000992	CcSEcCtD
Levobunolol—Paraesthesia—Perindopril—coronary artery disease	4.92e-05	0.000991	CcSEcCtD
Levobunolol—Urticaria—Niacin—coronary artery disease	4.91e-05	0.000989	CcSEcCtD
Levobunolol—Nausea—Acetylsalicylic acid—coronary artery disease	4.9e-05	0.000987	CcSEcCtD
Levobunolol—Pruritus—Eplerenone—coronary artery disease	4.89e-05	0.000985	CcSEcCtD
Levobunolol—Dyspnoea—Perindopril—coronary artery disease	4.89e-05	0.000984	CcSEcCtD
Levobunolol—Dizziness—Fenofibrate—coronary artery disease	4.88e-05	0.000982	CcSEcCtD
Levobunolol—Feeling abnormal—Trandolapril—coronary artery disease	4.87e-05	0.000981	CcSEcCtD
Levobunolol—Feeling abnormal—Enalapril—coronary artery disease	4.85e-05	0.000977	CcSEcCtD
Levobunolol—Syncope—Ramipril—coronary artery disease	4.85e-05	0.000976	CcSEcCtD
Levobunolol—Urticaria—Pravastatin—coronary artery disease	4.84e-05	0.000974	CcSEcCtD
Levobunolol—Asthenia—Simvastatin—coronary artery disease	4.83e-05	0.000973	CcSEcCtD
Levobunolol—Diarrhoea—Ezetimibe—coronary artery disease	4.83e-05	0.000973	CcSEcCtD
Levobunolol—Hypotension—Losartan—coronary artery disease	4.81e-05	0.000968	CcSEcCtD
Levobunolol—Dizziness—Clopidogrel—coronary artery disease	4.79e-05	0.000965	CcSEcCtD
Levobunolol—Paraesthesia—Furosemide—coronary artery disease	4.79e-05	0.000964	CcSEcCtD
Levobunolol—Feeling abnormal—Telmisartan—coronary artery disease	4.79e-05	0.000964	CcSEcCtD
Levobunolol—Palpitations—Ramipril—coronary artery disease	4.78e-05	0.000962	CcSEcCtD
Levobunolol—Pruritus—Simvastatin—coronary artery disease	4.76e-05	0.000959	CcSEcCtD
Levobunolol—Dizziness—Lovastatin—coronary artery disease	4.76e-05	0.000959	CcSEcCtD
Levobunolol—Loss of consciousness—Ramipril—coronary artery disease	4.75e-05	0.000956	CcSEcCtD
Levobunolol—Syncope—Timolol—coronary artery disease	4.74e-05	0.000954	CcSEcCtD
Levobunolol—Diarrhoea—Eplerenone—coronary artery disease	4.73e-05	0.000952	CcSEcCtD
Levobunolol—Urticaria—Trandolapril—coronary artery disease	4.7e-05	0.000946	CcSEcCtD
Levobunolol—Pain—Perindopril—coronary artery disease	4.69e-05	0.000944	CcSEcCtD
Levobunolol—Hypersensitivity—Valsartan—coronary artery disease	4.69e-05	0.000943	CcSEcCtD
Levobunolol—Urticaria—Enalapril—coronary artery disease	4.68e-05	0.000942	CcSEcCtD
Levobunolol—Dizziness—Ezetimibe—coronary artery disease	4.67e-05	0.00094	CcSEcCtD
Levobunolol—Palpitations—Timolol—coronary artery disease	4.67e-05	0.00094	CcSEcCtD
Levobunolol—Feeling abnormal—Captopril—coronary artery disease	4.65e-05	0.000937	CcSEcCtD
Levobunolol—Loss of consciousness—Timolol—coronary artery disease	4.64e-05	0.000935	CcSEcCtD
Levobunolol—Headache—Fenofibrate—coronary artery disease	4.62e-05	0.00093	CcSEcCtD
Levobunolol—Paraesthesia—Losartan—coronary artery disease	4.62e-05	0.00093	CcSEcCtD
Levobunolol—Urticaria—Telmisartan—coronary artery disease	4.61e-05	0.000929	CcSEcCtD
Levobunolol—Diarrhoea—Simvastatin—coronary artery disease	4.61e-05	0.000928	CcSEcCtD
Levobunolol—Chest pain—Ramipril—coronary artery disease	4.6e-05	0.000926	CcSEcCtD
Levobunolol—Dyspnoea—Losartan—coronary artery disease	4.59e-05	0.000923	CcSEcCtD
Levobunolol—Dizziness—Eplerenone—coronary artery disease	4.57e-05	0.00092	CcSEcCtD
Levobunolol—Asthenia—Valsartan—coronary artery disease	4.56e-05	0.000919	CcSEcCtD
Levobunolol—Pain—Furosemide—coronary artery disease	4.56e-05	0.000918	CcSEcCtD
Levobunolol—Hypersensitivity—Niacin—coronary artery disease	4.56e-05	0.000917	CcSEcCtD
Levobunolol—Asthenia—Olmesartan—coronary artery disease	4.54e-05	0.000914	CcSEcCtD
Levobunolol—Headache—Clopidogrel—coronary artery disease	4.54e-05	0.000914	CcSEcCtD
Levobunolol—Feeling abnormal—Perindopril—coronary artery disease	4.52e-05	0.00091	CcSEcCtD
Levobunolol—Headache—Lovastatin—coronary artery disease	4.51e-05	0.000908	CcSEcCtD
Levobunolol—Pruritus—Valsartan—coronary artery disease	4.5e-05	0.000906	CcSEcCtD
Levobunolol—Chest pain—Timolol—coronary artery disease	4.5e-05	0.000906	CcSEcCtD
Levobunolol—Hypersensitivity—Pravastatin—coronary artery disease	4.49e-05	0.000903	CcSEcCtD
Levobunolol—Pruritus—Olmesartan—coronary artery disease	4.48e-05	0.000902	CcSEcCtD
Levobunolol—Dizziness—Simvastatin—coronary artery disease	4.45e-05	0.000897	CcSEcCtD
Levobunolol—Confusional state—Ramipril—coronary artery disease	4.45e-05	0.000895	CcSEcCtD
Levobunolol—Asthenia—Niacin—coronary artery disease	4.44e-05	0.000893	CcSEcCtD
Levobunolol—Headache—Ezetimibe—coronary artery disease	4.42e-05	0.000891	CcSEcCtD
Levobunolol—Pain—Losartan—coronary artery disease	4.4e-05	0.000886	CcSEcCtD
Levobunolol—Syncope—Lisinopril—coronary artery disease	4.39e-05	0.000885	CcSEcCtD
Levobunolol—Feeling abnormal—Furosemide—coronary artery disease	4.39e-05	0.000885	CcSEcCtD
Levobunolol—Nausea—Fenofibrate—coronary artery disease	4.38e-05	0.000882	CcSEcCtD
Levobunolol—Pruritus—Niacin—coronary artery disease	4.37e-05	0.000881	CcSEcCtD
Levobunolol—Asthenia—Pravastatin—coronary artery disease	4.37e-05	0.00088	CcSEcCtD
Levobunolol—Urticaria—Perindopril—coronary artery disease	4.36e-05	0.000877	CcSEcCtD
Levobunolol—Hypersensitivity—Trandolapril—coronary artery disease	4.36e-05	0.000877	CcSEcCtD
Levobunolol—Diarrhoea—Valsartan—coronary artery disease	4.35e-05	0.000876	CcSEcCtD
Levobunolol—Confusional state—Timolol—coronary artery disease	4.35e-05	0.000875	CcSEcCtD
Levobunolol—Shock—Ramipril—coronary artery disease	4.34e-05	0.000874	CcSEcCtD
Levobunolol—Hypersensitivity—Enalapril—coronary artery disease	4.34e-05	0.000874	CcSEcCtD
Levobunolol—Palpitations—Lisinopril—coronary artery disease	4.33e-05	0.000872	CcSEcCtD
Levobunolol—Diarrhoea—Olmesartan—coronary artery disease	4.33e-05	0.000872	CcSEcCtD
Levobunolol—Headache—Eplerenone—coronary artery disease	4.33e-05	0.000872	CcSEcCtD
Levobunolol—Pruritus—Pravastatin—coronary artery disease	4.31e-05	0.000867	CcSEcCtD
Levobunolol—Loss of consciousness—Lisinopril—coronary artery disease	4.31e-05	0.000867	CcSEcCtD
Levobunolol—Nausea—Clopidogrel—coronary artery disease	4.3e-05	0.000867	CcSEcCtD
Levobunolol—Hypersensitivity—Telmisartan—coronary artery disease	4.28e-05	0.000862	CcSEcCtD
Levobunolol—Nausea—Lovastatin—coronary artery disease	4.28e-05	0.000861	CcSEcCtD
Levobunolol—Asthenia—Trandolapril—coronary artery disease	4.24e-05	0.000854	CcSEcCtD
Levobunolol—Shock—Timolol—coronary artery disease	4.24e-05	0.000854	CcSEcCtD
Levobunolol—Feeling abnormal—Losartan—coronary artery disease	4.24e-05	0.000853	CcSEcCtD
Levobunolol—Urticaria—Furosemide—coronary artery disease	4.23e-05	0.000853	CcSEcCtD
Levobunolol—Diarrhoea—Niacin—coronary artery disease	4.23e-05	0.000852	CcSEcCtD
Levobunolol—Asthenia—Enalapril—coronary artery disease	4.22e-05	0.000851	CcSEcCtD
Levobunolol—Headache—Simvastatin—coronary artery disease	4.22e-05	0.000849	CcSEcCtD
Levobunolol—Dizziness—Valsartan—coronary artery disease	4.21e-05	0.000847	CcSEcCtD
Levobunolol—Nausea—Ezetimibe—coronary artery disease	4.19e-05	0.000845	CcSEcCtD
Levobunolol—Dizziness—Olmesartan—coronary artery disease	4.19e-05	0.000843	CcSEcCtD
Levobunolol—Pruritus—Trandolapril—coronary artery disease	4.18e-05	0.000842	CcSEcCtD
Levobunolol—Chest pain—Lisinopril—coronary artery disease	4.17e-05	0.00084	CcSEcCtD
Levobunolol—Asthenia—Telmisartan—coronary artery disease	4.17e-05	0.000839	CcSEcCtD
Levobunolol—Pruritus—Enalapril—coronary artery disease	4.17e-05	0.000839	CcSEcCtD
Levobunolol—Diarrhoea—Pravastatin—coronary artery disease	4.17e-05	0.000839	CcSEcCtD
Levobunolol—Hypotension—Ramipril—coronary artery disease	4.12e-05	0.00083	CcSEcCtD
Levobunolol—Pruritus—Telmisartan—coronary artery disease	4.11e-05	0.000827	CcSEcCtD
Levobunolol—Nausea—Eplerenone—coronary artery disease	4.11e-05	0.000827	CcSEcCtD
Levobunolol—Dizziness—Niacin—coronary artery disease	4.09e-05	0.000823	CcSEcCtD
Levobunolol—Urticaria—Losartan—coronary artery disease	4.09e-05	0.000823	CcSEcCtD
Levobunolol—Asthenia—Captopril—coronary artery disease	4.05e-05	0.000816	CcSEcCtD
Levobunolol—Diarrhoea—Trandolapril—coronary artery disease	4.05e-05	0.000815	CcSEcCtD
Levobunolol—Confusional state—Lisinopril—coronary artery disease	4.03e-05	0.000812	CcSEcCtD
Levobunolol—Diarrhoea—Enalapril—coronary artery disease	4.03e-05	0.000811	CcSEcCtD
Levobunolol—Hypotension—Timolol—coronary artery disease	4.03e-05	0.000811	CcSEcCtD
Levobunolol—Dizziness—Pravastatin—coronary artery disease	4.03e-05	0.000811	CcSEcCtD
Levobunolol—Nausea—Simvastatin—coronary artery disease	4e-05	0.000805	CcSEcCtD
Levobunolol—Pruritus—Captopril—coronary artery disease	4e-05	0.000805	CcSEcCtD
Levobunolol—Headache—Valsartan—coronary artery disease	3.98e-05	0.000802	CcSEcCtD
Levobunolol—Diarrhoea—Telmisartan—coronary artery disease	3.97e-05	0.0008	CcSEcCtD
Levobunolol—Headache—Olmesartan—coronary artery disease	3.96e-05	0.000798	CcSEcCtD
Levobunolol—Paraesthesia—Ramipril—coronary artery disease	3.96e-05	0.000797	CcSEcCtD
Levobunolol—Shock—Lisinopril—coronary artery disease	3.93e-05	0.000792	CcSEcCtD
Levobunolol—Asthenia—Perindopril—coronary artery disease	3.93e-05	0.000792	CcSEcCtD
Levobunolol—Dyspnoea—Ramipril—coronary artery disease	3.93e-05	0.000792	CcSEcCtD
Levobunolol—Hypersensitivity—Furosemide—coronary artery disease	3.93e-05	0.000791	CcSEcCtD
Levobunolol—Dizziness—Trandolapril—coronary artery disease	3.91e-05	0.000787	CcSEcCtD
Levobunolol—Dizziness—Enalapril—coronary artery disease	3.89e-05	0.000784	CcSEcCtD
Levobunolol—Pruritus—Perindopril—coronary artery disease	3.88e-05	0.000781	CcSEcCtD
Levobunolol—Headache—Niacin—coronary artery disease	3.87e-05	0.00078	CcSEcCtD
Levobunolol—Paraesthesia—Timolol—coronary artery disease	3.87e-05	0.00078	CcSEcCtD
Levobunolol—Diarrhoea—Captopril—coronary artery disease	3.86e-05	0.000778	CcSEcCtD
Levobunolol—Dyspnoea—Timolol—coronary artery disease	3.84e-05	0.000774	CcSEcCtD
Levobunolol—Dizziness—Telmisartan—coronary artery disease	3.84e-05	0.000773	CcSEcCtD
Levobunolol—Asthenia—Furosemide—coronary artery disease	3.82e-05	0.00077	CcSEcCtD
Levobunolol—Headache—Pravastatin—coronary artery disease	3.81e-05	0.000768	CcSEcCtD
Levobunolol—Hypersensitivity—Losartan—coronary artery disease	3.79e-05	0.000763	CcSEcCtD
Levobunolol—Nausea—Valsartan—coronary artery disease	3.78e-05	0.000761	CcSEcCtD
Levobunolol—Pruritus—Furosemide—coronary artery disease	3.77e-05	0.000759	CcSEcCtD
Levobunolol—Propranolol—ADRB1—coronary artery disease	3.76e-05	0.0242	CrCbGaD
Levobunolol—Nausea—Olmesartan—coronary artery disease	3.76e-05	0.000757	CcSEcCtD
Levobunolol—Diarrhoea—Perindopril—coronary artery disease	3.75e-05	0.000755	CcSEcCtD
Levobunolol—Hypotension—Lisinopril—coronary artery disease	3.74e-05	0.000753	CcSEcCtD
Levobunolol—Dizziness—Captopril—coronary artery disease	3.73e-05	0.000752	CcSEcCtD
Levobunolol—Headache—Trandolapril—coronary artery disease	3.7e-05	0.000746	CcSEcCtD
Levobunolol—Asthenia—Losartan—coronary artery disease	3.69e-05	0.000743	CcSEcCtD
Levobunolol—Headache—Enalapril—coronary artery disease	3.69e-05	0.000743	CcSEcCtD
Levobunolol—Pain—Timolol—coronary artery disease	3.69e-05	0.000742	CcSEcCtD
Levobunolol—Nausea—Niacin—coronary artery disease	3.67e-05	0.00074	CcSEcCtD
Levobunolol—Diarrhoea—Furosemide—coronary artery disease	3.65e-05	0.000734	CcSEcCtD
Levobunolol—Pruritus—Losartan—coronary artery disease	3.64e-05	0.000733	CcSEcCtD
Levobunolol—Headache—Telmisartan—coronary artery disease	3.64e-05	0.000733	CcSEcCtD
Levobunolol—Feeling abnormal—Ramipril—coronary artery disease	3.63e-05	0.000732	CcSEcCtD
Levobunolol—Dizziness—Perindopril—coronary artery disease	3.63e-05	0.00073	CcSEcCtD
Levobunolol—Nausea—Pravastatin—coronary artery disease	3.62e-05	0.000728	CcSEcCtD
Levobunolol—Paraesthesia—Lisinopril—coronary artery disease	3.59e-05	0.000723	CcSEcCtD
Levobunolol—Dyspnoea—Lisinopril—coronary artery disease	3.57e-05	0.000718	CcSEcCtD
Levobunolol—Feeling abnormal—Timolol—coronary artery disease	3.55e-05	0.000715	CcSEcCtD
Levobunolol—Headache—Captopril—coronary artery disease	3.54e-05	0.000712	CcSEcCtD
Levobunolol—Dizziness—Furosemide—coronary artery disease	3.52e-05	0.00071	CcSEcCtD
Levobunolol—Diarrhoea—Losartan—coronary artery disease	3.52e-05	0.000709	CcSEcCtD
Levobunolol—Nausea—Trandolapril—coronary artery disease	3.51e-05	0.000707	CcSEcCtD
Levobunolol—Urticaria—Ramipril—coronary artery disease	3.5e-05	0.000705	CcSEcCtD
Levobunolol—Nausea—Enalapril—coronary artery disease	3.5e-05	0.000704	CcSEcCtD
Levobunolol—Nausea—Telmisartan—coronary artery disease	3.45e-05	0.000695	CcSEcCtD
Levobunolol—Headache—Perindopril—coronary artery disease	3.44e-05	0.000692	CcSEcCtD
Levobunolol—Urticaria—Timolol—coronary artery disease	3.43e-05	0.00069	CcSEcCtD
Levobunolol—Pain—Lisinopril—coronary artery disease	3.42e-05	0.000689	CcSEcCtD
Levobunolol—Dizziness—Losartan—coronary artery disease	3.4e-05	0.000685	CcSEcCtD
Levobunolol—Nausea—Captopril—coronary artery disease	3.35e-05	0.000676	CcSEcCtD
Levobunolol—Headache—Furosemide—coronary artery disease	3.34e-05	0.000672	CcSEcCtD
Levobunolol—Feeling abnormal—Lisinopril—coronary artery disease	3.3e-05	0.000664	CcSEcCtD
Levobunolol—Nausea—Perindopril—coronary artery disease	3.26e-05	0.000656	CcSEcCtD
Levobunolol—Hypersensitivity—Ramipril—coronary artery disease	3.25e-05	0.000654	CcSEcCtD
Levobunolol—Headache—Losartan—coronary artery disease	3.22e-05	0.000649	CcSEcCtD
Levobunolol—Urticaria—Lisinopril—coronary artery disease	3.18e-05	0.00064	CcSEcCtD
Levobunolol—Hypersensitivity—Timolol—coronary artery disease	3.18e-05	0.00064	CcSEcCtD
Levobunolol—Nausea—Furosemide—coronary artery disease	3.17e-05	0.000638	CcSEcCtD
Levobunolol—Propranolol—ADRB2—coronary artery disease	3.17e-05	0.0203	CrCbGaD
Levobunolol—Asthenia—Ramipril—coronary artery disease	3.16e-05	0.000637	CcSEcCtD
Levobunolol—Pruritus—Ramipril—coronary artery disease	3.12e-05	0.000628	CcSEcCtD
Levobunolol—Asthenia—Timolol—coronary artery disease	3.09e-05	0.000623	CcSEcCtD
Levobunolol—Nausea—Losartan—coronary artery disease	3.06e-05	0.000615	CcSEcCtD
Levobunolol—Pruritus—Timolol—coronary artery disease	3.05e-05	0.000614	CcSEcCtD
Levobunolol—Diarrhoea—Ramipril—coronary artery disease	3.02e-05	0.000608	CcSEcCtD
Levobunolol—Diarrhoea—Timolol—coronary artery disease	2.95e-05	0.000594	CcSEcCtD
Levobunolol—Hypersensitivity—Lisinopril—coronary artery disease	2.95e-05	0.000593	CcSEcCtD
Levobunolol—Dizziness—Ramipril—coronary artery disease	2.92e-05	0.000587	CcSEcCtD
Levobunolol—Asthenia—Lisinopril—coronary artery disease	2.87e-05	0.000578	CcSEcCtD
Levobunolol—Dizziness—Timolol—coronary artery disease	2.85e-05	0.000574	CcSEcCtD
Levobunolol—Pruritus—Lisinopril—coronary artery disease	2.83e-05	0.00057	CcSEcCtD
Levobunolol—Headache—Ramipril—coronary artery disease	2.76e-05	0.000556	CcSEcCtD
Levobunolol—Diarrhoea—Lisinopril—coronary artery disease	2.74e-05	0.000551	CcSEcCtD
Levobunolol—Propranolol—CYP2C19—coronary artery disease	2.73e-05	0.0175	CrCbGaD
Levobunolol—Headache—Timolol—coronary artery disease	2.7e-05	0.000544	CcSEcCtD
Levobunolol—Dizziness—Lisinopril—coronary artery disease	2.64e-05	0.000533	CcSEcCtD
Levobunolol—Nausea—Ramipril—coronary artery disease	2.62e-05	0.000527	CcSEcCtD
Levobunolol—Nausea—Timolol—coronary artery disease	2.56e-05	0.000516	CcSEcCtD
Levobunolol—Headache—Lisinopril—coronary artery disease	2.51e-05	0.000505	CcSEcCtD
Levobunolol—Nausea—Lisinopril—coronary artery disease	2.38e-05	0.000478	CcSEcCtD
Levobunolol—ADRB2—Signaling Pathways—GNA12—coronary artery disease	6.2e-06	0.000377	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BDKRB1—coronary artery disease	6.2e-06	0.000377	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—P4HB—coronary artery disease	6.2e-06	0.000377	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CX3CL1—coronary artery disease	6.2e-06	0.000377	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADM—coronary artery disease	6.17e-06	0.000375	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCE—coronary artery disease	6.16e-06	0.000374	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDN1—coronary artery disease	6.14e-06	0.000373	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CSF2—coronary artery disease	6.14e-06	0.000373	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCL5—coronary artery disease	6.1e-06	0.00037	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP3R1—coronary artery disease	6.09e-06	0.00037	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADM—coronary artery disease	6.03e-06	0.000366	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDE4B—coronary artery disease	6.01e-06	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CYBB—coronary artery disease	6.01e-06	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CXCL8—coronary artery disease	6.01e-06	0.000365	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CSF2—coronary artery disease	6e-06	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MMP3—coronary artery disease	6e-06	0.000364	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDE4B—coronary artery disease	5.88e-06	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CYBB—coronary artery disease	5.88e-06	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CXCL8—coronary artery disease	5.88e-06	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MMP3—coronary artery disease	5.87e-06	0.000356	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDN1—coronary artery disease	5.7e-06	0.000346	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL5—coronary artery disease	5.66e-06	0.000344	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCD—coronary artery disease	5.61e-06	0.000341	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDN1—coronary artery disease	5.58e-06	0.000339	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CSF2—coronary artery disease	5.57e-06	0.000339	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL5—coronary artery disease	5.54e-06	0.000336	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR3—coronary artery disease	5.5e-06	0.000334	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—coronary artery disease	5.49e-06	0.000334	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCD—coronary artery disease	5.49e-06	0.000334	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—C3—coronary artery disease	5.49e-06	0.000333	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CSF2—coronary artery disease	5.45e-06	0.000331	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CRK—coronary artery disease	5.43e-06	0.00033	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR3—coronary artery disease	5.38e-06	0.000327	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—coronary artery disease	5.37e-06	0.000326	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—C3—coronary artery disease	5.37e-06	0.000326	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SH2B3—coronary artery disease	5.36e-06	0.000325	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VWF—coronary artery disease	5.36e-06	0.000325	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ATP2A2—coronary artery disease	5.36e-06	0.000325	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOC3—coronary artery disease	5.32e-06	0.000323	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CRK—coronary artery disease	5.31e-06	0.000322	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LDLR—coronary artery disease	5.29e-06	0.000321	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SH2B3—coronary artery disease	5.24e-06	0.000318	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VWF—coronary artery disease	5.24e-06	0.000318	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ATP2A2—coronary artery disease	5.24e-06	0.000318	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGT—coronary artery disease	5.21e-06	0.000317	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOC3—coronary artery disease	5.21e-06	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP2CA—coronary artery disease	5.19e-06	0.000315	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LDLR—coronary artery disease	5.18e-06	0.000314	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL2—coronary artery disease	5.17e-06	0.000314	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL3—coronary artery disease	5.17e-06	0.000314	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SDC1—coronary artery disease	5.11e-06	0.00031	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—F2R—coronary artery disease	5.11e-06	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGT—coronary artery disease	5.1e-06	0.00031	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCD—coronary artery disease	5.1e-06	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP2CA—coronary artery disease	5.08e-06	0.000309	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL3—coronary artery disease	5.06e-06	0.000307	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL2—coronary artery disease	5.06e-06	0.000307	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGB—coronary artery disease	5e-06	0.000304	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SDC1—coronary artery disease	5e-06	0.000304	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—F2R—coronary artery disease	5e-06	0.000304	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—coronary artery disease	4.99e-06	0.000303	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCD—coronary artery disease	4.99e-06	0.000303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—C3—coronary artery disease	4.98e-06	0.000303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRB—coronary artery disease	4.95e-06	0.000301	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGB—coronary artery disease	4.89e-06	0.000297	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—coronary artery disease	4.88e-06	0.000296	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—THBS1—coronary artery disease	4.88e-06	0.000296	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—C3—coronary artery disease	4.87e-06	0.000296	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRB—coronary artery disease	4.84e-06	0.000294	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSMB5—coronary artery disease	4.83e-06	0.000293	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSMA6—coronary artery disease	4.83e-06	0.000293	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—F2—coronary artery disease	4.82e-06	0.000293	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—THBS1—coronary artery disease	4.77e-06	0.00029	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGT—coronary artery disease	4.73e-06	0.000288	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSMB5—coronary artery disease	4.72e-06	0.000287	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSMA6—coronary artery disease	4.72e-06	0.000287	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—F2—coronary artery disease	4.71e-06	0.000286	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRA—coronary artery disease	4.67e-06	0.000284	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CYBA—coronary artery disease	4.65e-06	0.000283	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DUSP6—coronary artery disease	4.63e-06	0.000281	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGT—coronary artery disease	4.63e-06	0.000281	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRA—coronary artery disease	4.57e-06	0.000278	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLAT—coronary artery disease	4.55e-06	0.000277	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB1—coronary artery disease	4.55e-06	0.000277	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CYBA—coronary artery disease	4.55e-06	0.000277	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	4.53e-06	0.000275	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	4.46e-06	0.000271	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	4.39e-06	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	4.39e-06	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	4.39e-06	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—F2—coronary artery disease	4.37e-06	0.000266	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	4.36e-06	0.000265	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	4.31e-06	0.000262	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	4.3e-06	0.000261	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	4.3e-06	0.000261	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	4.3e-06	0.000261	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	4.29e-06	0.000261	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	4.28e-06	0.00026	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	4.26e-06	0.000259	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	4.22e-06	0.000256	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	4.21e-06	0.000256	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	4.2e-06	0.000255	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	4.12e-06	0.00025	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	4.01e-06	0.000244	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	4e-06	0.000243	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	3.98e-06	0.000242	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	3.98e-06	0.000242	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	3.97e-06	0.000241	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	3.92e-06	0.000238	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	3.91e-06	0.000238	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	3.9e-06	0.000237	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	3.9e-06	0.000237	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	3.9e-06	0.000237	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	3.89e-06	0.000236	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	3.89e-06	0.000236	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	3.88e-06	0.000236	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	3.87e-06	0.000235	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	3.81e-06	0.000232	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	3.8e-06	0.000231	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	3.8e-06	0.000231	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	3.79e-06	0.00023	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	3.77e-06	0.000229	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	3.72e-06	0.000226	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	3.72e-06	0.000226	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	3.71e-06	0.000226	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	3.7e-06	0.000225	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	3.67e-06	0.000223	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	3.64e-06	0.000221	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	3.64e-06	0.000221	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	3.63e-06	0.000221	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	3.62e-06	0.00022	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	3.62e-06	0.00022	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	3.62e-06	0.00022	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	3.59e-06	0.000218	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	3.55e-06	0.000215	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	3.55e-06	0.000215	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	3.54e-06	0.000215	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	3.54e-06	0.000215	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	3.46e-06	0.00021	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	3.46e-06	0.00021	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	3.42e-06	0.000208	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	3.39e-06	0.000206	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	3.38e-06	0.000205	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	3.37e-06	0.000205	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	3.35e-06	0.000203	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	3.34e-06	0.000203	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	3.32e-06	0.000202	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	3.3e-06	0.000201	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	3.3e-06	0.0002	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	3.29e-06	0.0002	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	3.29e-06	0.0002	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	3.27e-06	0.000199	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	3.27e-06	0.000199	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	3.24e-06	0.000197	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	3.24e-06	0.000197	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	3.22e-06	0.000196	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	3.22e-06	0.000196	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	3.2e-06	0.000194	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	3.17e-06	0.000193	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	3.17e-06	0.000193	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	3.16e-06	0.000192	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	3.09e-06	0.000188	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	3.08e-06	0.000187	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	3.07e-06	0.000186	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	3.02e-06	0.000183	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	3.01e-06	0.000183	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	3e-06	0.000182	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.95e-06	0.000179	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.95e-06	0.000179	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.94e-06	0.000179	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.88e-06	0.000175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.88e-06	0.000175	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.81e-06	0.000171	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.8e-06	0.00017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.75e-06	0.000167	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.74e-06	0.000166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.74e-06	0.000166	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.74e-06	0.000166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.71e-06	0.000165	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.68e-06	0.000163	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.68e-06	0.000163	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.68e-06	0.000163	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.67e-06	0.000162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.65e-06	0.000161	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.63e-06	0.00016	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.62e-06	0.000159	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.61e-06	0.000158	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.58e-06	0.000157	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.58e-06	0.000157	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.57e-06	0.000156	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.56e-06	0.000155	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.55e-06	0.000155	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.53e-06	0.000154	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.53e-06	0.000154	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.52e-06	0.000153	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.5e-06	0.000152	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.47e-06	0.00015	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.42e-06	0.000147	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2.37e-06	0.000144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	2.35e-06	0.000143	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	2.35e-06	0.000143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	2.32e-06	0.000141	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.3e-06	0.00014	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	2.3e-06	0.00014	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	2.3e-06	0.00014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.3e-06	0.000139	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.26e-06	0.000138	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.25e-06	0.000137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	2.25e-06	0.000137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	2.25e-06	0.000136	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	2.21e-06	0.000135	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	2.2e-06	0.000134	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.15e-06	0.000131	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	2.15e-06	0.000131	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.11e-06	0.000128	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	2.1e-06	0.000128	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	2.08e-06	0.000126	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.05e-06	0.000125	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.04e-06	0.000124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.01e-06	0.000122	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2e-06	0.000121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.96e-06	0.000119	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.95e-06	0.000119	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.91e-06	0.000116	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.82e-06	0.000111	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.78e-06	0.000108	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.76e-06	0.000107	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.74e-06	0.000106	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.73e-06	0.000105	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.72e-06	0.000105	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.7e-06	0.000104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	0.000103	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.69e-06	0.000103	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.66e-06	0.000101	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	0.0001	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.61e-06	9.79e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.6e-06	9.7e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.56e-06	9.49e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	8.98e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.45e-06	8.79e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	8.25e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	8.09e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.33e-06	8.07e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.3e-06	7.91e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	7.02e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.13e-06	6.86e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.02e-06	6.21e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1e-06	6.08e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	9.44e-07	5.73e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	9.23e-07	5.61e-05	CbGpPWpGaD
